COVID-19 updates: Elizabeth Warren tests positive
The senator says she's experiencing "mild symptoms."
As the COVID-19 pandemic has swept the globe, more than 5.3 million people have died from the disease worldwide, including over 806,000 Americans, according to real-time data compiled by Johns Hopkins University's Center for Systems Science and Engineering.
About 61.4% of the population in the United States is fully vaccinated against COVID-19, according to data from the Centers for Disease Control and Prevention.
Latest headlines:
South Africa's president tests positive for COVID-19
South African President Cyril Ramaphosa is receiving treatment for "mild COVID-19 symptoms" after testing positive for the virus on Sunday, his office said in a statement.
Ramaphosa, 69, began feeling unwell earlier Sunday after leaving a state memorial service in Cape Town in honor of Frederik Willem de Klerk, South Africa's last apartheid president and a Nobel laureate, who died last month. Ramaphosa, who is fully vaccinated against COVID-19, was experiencing "mild" symptoms and a test confirmed he was infected, according to his office. The statement didn't say whether he has the omicron variant, which was discovered by scientists in southern Africa last month and is spreading rapidly.
Ramaphosa is self-isolating in Cape Town and is being monitored by the South African Military Health Service. He has delegated all his responsibilities to Deputy President David Mabuza for the next week, his office said.
Last week, Ramaphosa traveled with a delegation to four West African nations. He and the members of the South African delegation were all tested for COVID-19 in each of the countries during their trip. They returned to South Africa on Dec. 8, after testing negative in Senegal. Ramaphosa tested negative again upon arriving in Johannesburg that day, according to his office.
The statement advised people who had contact with the South African president on Sunday to watch for symptoms or to get tested for COVID-19.
"President Ramaphosa says his own infection serves as a caution to all people in the country to be vaccinated and remain vigilant against exposure," his office said in the statement. "Vaccination remains the best protection against severe illness and hospitalization."
-ABC News' Christine Theodorou
Vaccine timeline pushed back for kids under 5
The potential timeline for when children under 5 may have an authorized vaccine is now being pushed back.
Data for a two-shot vaccine was initially expected by the end of the year, but now Pfizer/BioNTech say they hope to have data with a third shot in the first half of 2022.
Pfizer/BioNTech said they "will amend the clinical study evaluating the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months to under 5 years of age. The study will now include evaluating a third dose of 3 µg at least two months after the second dose of the two-dose series to provide high levels of protection in this young age group."
An early look into the study data suggested that the two doses at a smaller volume was not as effective for kids ages 2 to 5 as it was for the 16 to 25 population, so scientists are going to add a third dose and see if the vaccine is as effective. There were no safety issues reported in the early data analysis.
Pfizer/BioNTech added in a statement, “The decision to evaluate a third dose of 3 µg for children 6 months to under 5 years of age reflects the companies’ commitment to carefully select the right dose to maximize the risk-benefit profile. If the three-dose study is successful, Pfizer and BioNTech expect to submit data to regulators to support an Emergency Use Authorization (EUA) for children 6 months to under 5 years of age in the first half of 2022.”
-ABC News' Eric M. Strauss